InfuSystem Holdings, Inc. (NYSE:INFU - Get Free Report) CFO Barry G. Steele bought 3,000 shares of the business's stock in a transaction that occurred on Wednesday, May 14th. The stock was purchased at an average price of $5.76 per share, for a total transaction of $17,280.00. Following the completion of the acquisition, the chief financial officer now owns 76,887 shares in the company, valued at $442,869.12. This represents a 4.06% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link.
InfuSystem Trading Down 0.3%
NYSE:INFU opened at $5.73 on Thursday. InfuSystem Holdings, Inc. has a 52 week low of $4.61 and a 52 week high of $9.97. The firm has a 50-day moving average price of $5.26 and a two-hundred day moving average price of $7.13. The firm has a market cap of $120.42 million, a price-to-earnings ratio of 95.52 and a beta of 1.73. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.59 and a current ratio of 1.98.
Analyst Ratings Changes
A number of research analysts have weighed in on INFU shares. StockNews.com lowered shares of InfuSystem from a "strong-buy" rating to a "buy" rating in a research note on Wednesday. Sidoti upgraded InfuSystem to a "strong-buy" rating in a report on Tuesday, March 18th. Finally, B. Riley upgraded InfuSystem to a "strong-buy" rating in a report on Thursday, May 8th.
View Our Latest Report on InfuSystem
Institutional Trading of InfuSystem
A number of hedge funds have recently bought and sold shares of the business. BNP Paribas Financial Markets increased its position in shares of InfuSystem by 67.9% during the 4th quarter. BNP Paribas Financial Markets now owns 6,844 shares of the company's stock valued at $58,000 after purchasing an additional 2,768 shares during the last quarter. Jump Financial LLC bought a new stake in InfuSystem in the first quarter worth about $58,000. Wells Fargo & Company MN boosted its stake in InfuSystem by 51.7% in the fourth quarter. Wells Fargo & Company MN now owns 9,286 shares of the company's stock valued at $78,000 after acquiring an additional 3,165 shares during the last quarter. Legato Capital Management LLC purchased a new stake in shares of InfuSystem during the 4th quarter worth approximately $85,000. Finally, Summit Global Investments bought a new stake in shares of InfuSystem in the 4th quarter worth approximately $86,000. 71.13% of the stock is currently owned by institutional investors.
About InfuSystem
(
Get Free Report)
InfuSystem Holdings, Inc, through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider InfuSystem, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and InfuSystem wasn't on the list.
While InfuSystem currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
